Variant NM_000492.4:c.3484C>T
| Name | NM_000492.4:c.3484C>T |
| Protein name | NP_000483.3:p.(Arg1162*) |
| Genomic name (hg19) | chr7:g.117267591C>T UCSC |
| Genomic name (hg38) | chr7:g.117627537C>T UCSC |
| #Exon/intron | exon 22 |
| Legacy Name | R1162X |
| Class | disease-causing |
| Subclass | CF-causing |
| WT sequence | TTTATTTCAGATGCGATCTGTGAGC C GAGTCTTTAAGTTCATTGACATGCC |
| Mutant sequence | TTTATTTCAGATGCGATCTGTGAGC T GAGTCTTTAAGTTCATTGACATGCC |
![]() |
![]() | dbSNP rs74767530 |
![]() Not found | ![]() |
| Reference | PMID | Modulator | in vitro / ex vivo data | clinical data | Patient responsiveness |
| Burgel et al., 2024 | 39151434 | ELX-TEZ-IVA | N.D. | yes | no |
No patient found in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 36 |
|---|---|
| Asymptomatic compound heterozygote | 1 |
| CF | 29 |
| CFTR-RD | 4
|
| Pending | 1 |
| Pending (NBS) | 1 |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| CF | 6105 | heterozygote | CF-causing- Undef |
| CF | 2048 | heterozygote | CF-causing- Undef |
| CF | 2548 | heterozygote | CF-causing- Undef |
| CF | 3171 | heterozygote | CF-causing- Undef |
| CF | 3179 | heterozygote | CF-causing - Trans |
| CF | 3400 | heterozygote | CF-causing - Trans |
| CF | 3418 | heterozygote | CF-causing - Trans |
| CF | 3436 | heterozygote | CF-causing- Undef |
| CF | 3505 | heterozygote | CF-causing- Undef |
| CF | 3685 | heterozygote | CF-causing - Trans |
| CF | 4098 | heterozygote | CF-causing- Undef |
| CF | 4206 | heterozygote | CF-causing- Undef |
| CF | 4507 | heterozygote | CF-causing- Undef |
| CF | 4521 | heterozygote | CF-causing - Trans |
| CF | 6253 | heterozygote | CF-causing - Trans |
| CF | 5373 | heterozygote | varying clinical consequence- Undef |
| CF | 5113 | heterozygote | VUS3- Undef |
| CF | 616 | heterozygote | CF-causing - Trans |
| CF | 637 | heterozygote | varying clinical consequence - Trans |
| CF | 649 | heterozygote | CF-causing - Trans |
| CF | 706 | heterozygote | CF-causing - Trans |
| CF | 929 | heterozygote | CF-causing - Trans |
| CF | 1085 | heterozygote | CF-causing - Trans |
| CF | 1150 | heterozygote | CF-causing - Trans |
| CF | 1298 | heterozygote | CF-causing - Trans |
| CF | 1531 | heterozygote | CF-causing - Trans |
| CF | 1652 | heterozygote | CF-causing- Undef |
| CF | 2567 | homozygote | c.3484C>T - p.(Arg1162*) - Trans |
| CF | 22 | homozygote | c.3484C>T - p.(Arg1162*) - Trans |
| Other | 464 | heterozygote | CFTR-RD-causing- Undef |
| Asymptomatic compound heterozygote | 5812 | heterozygote | |
| CBAVD | 5819 | heterozygote | CFTR-RD-causing- Undef |
| CBAVD | 1430 | heterozygote | CFTR-RD-causing - Trans |
| CBAVD | 5002 | heterozygote | VUS3- Undef |
| Pending | 3035 | heterozygote | |
| Pending (NBS) | 4555 | heterozygote | CFTR-RD-causing- Undef |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|